National symposium to feature Ana Casanegra, M.D. reviewing direct-acting anticoagulants
On Dec. 4, Mayo Clinic Laboratories will host the Friday Satellite Symposium A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis, preceding the 62nd American Society of Hematology Annual Meeting and Exposition.
As part of this symposium, Ana Casanegra, M.D., will present "Measurement of Direct-Acting Anticoagulants: Clinical and Laboratory Issues."
Dr. Casanegra is an associate professor of Medicine at Mayo Clinic College of Medicine and Science, with a primary appointment in the Department of Cardiovascular Diseases where she is the vice chair of the Division of Vascular Medicine. She also is director of Mayo Clinic's Thrombophilia and Thrombosis Clinic. Dr. Casanegra participates in a prospective registry of evidence-based medicine and patient-centered shared decision making for management of deep vein thrombosis and venous thromboembolism.
Prior to joining Mayo Clinic's Vascular Division in 2016, Dr. Cadanegra completed vascular medicine fellowships in Argentina and at Cleveland Clinic. She earned a master's degree in clinical and translational research at the University of Oklahoma's School of Public Health. Her research interests involve venous thrombosis prevention and treatment, including complex thrombophilia evaluation and management, and diagnosis of vascular diseases.
The symposium agenda, information about continuing education credits, and registration details are available on the event website. Registration is limited to 300 attendees. The deadline to register is Thursday, Dec. 3, at 5 p.m. CT.